Time course of total cysteine, glutathione and homocysteine in plasma of patients with chronic hepatitis C treated with interferon-α with and without supplementation with N-acetylcysteine

Journal of Hepatology

Volumn 28, Issue 5, 1998, Pages 751-755

  Bernhard, Marie Claire ^a   Junker, Edith ^a   Hettinger, Angelika ^a   Lauterburg, Bernhard H ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Glutathione; Hepatitis C; Interferon ; N acetylcysteine

Indexed keywords

ACETYLCYSTEINE; ALPHA INTERFERON; ALPHAN1 INTERFERON; CYSTEINE; GLUTATHIONE; HOMOCYSTEINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERIVATIZATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEPATITIS C; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

EID: 0032080212     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80223-7     Document Type: Article

References (25)

1. Poynard T, Leroy V, Cohard M, Thevenot T, Mathurin P, Opolon P, et al. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology. 24:1996;778-789.
2. Burgunder JM, Lauterburg BH. Decreased production of glutathione in patients with cirrhosis. Eur J Clin Invest. 17:1987;408-414.
3. Horowitz JH, Rypins EB, Henderson JM, Heymsfield SB, Moffitt SD, Bain RP, et al. Evidence for impairment of transsulfuration pathway in cirrhosis. Gastroenterology. 81:1981;668-675.
4. Staal FJT, Ela SW, Roederer M, Anderson MT, Herzenberg LA. Glutathione deficiency and human immunodeficiency virus infection. Lancet. 339:1992;909-912.
5. DeQuay B, Malinverni R, Lauterburg BH. Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteine. AIDS. 6:1992;815-819.
6. Helbling B, Von Overbeck J, Lauterburg BH. Decreased synthesis of glutathione in patients with AIDS. Eur J Clin Invest. 26:1996;38-44.
7. Dröge W, Eck HP, Mihm S. HIV-induced cysteine deficiency and T-cell dysfunction: a rationale for treatment with N-acetylcysteine. Immunol Today. 13:1992;211-214.
8. Herzenberg LA, De Rosa SC, Dubs JG, Roederer M, Anderson MT, Ela SW, et al. Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci USA. 94:1997;1967-1972.
9. Kinscherf R, Fischbach T, Mihm S, Roth S, Hohenhaussievert E, Weiss C, et al. Effect of glutathione depletion and oral N-acetyl-cysteine treatment on CD4(+) and CD8(+) cells. FASEB J. 8:1994;448-451.
10. Kalebic T, Kinter A, Poli G, Anderson ME, Meister A, Fauci AS. Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine. Proc Natl Acad Sci USA. 88:1991;986-990.
11. Palamara AT, Perno CF, Aquaro S, Buè MC, Dini L, Garaci E. Glutathione inhibits HIV replication by acting at late stages of the virus life cycle. AIDS Res Hum Retroviruses. 12:1996;1537-1541.
12. Weiss L, Hildt E, Hofschneider PH. Anti-hepatitis B virus activity of N-acetyl-L-cysteine (NAC): new aspects of a well-established drug. Antiviral Res. 32:1996;43-53.
13. Buhl R, Holroyd KJ, Mastrangeli A, Cantin AM, Jaffe HA, Wells FB, et al. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet. ii:1989;1294-1298.
14. Suarez M, Beloqui O, Ferrer V, Gil B, Qian C, Garcia N, et al. Glutathione depletion in chronic hepatitis C. Int Hepatol Commun. 1:1993;215-221.
15. Beloqui O, Prieto J, Suarez M, Gil B, Qian CH, Garcia N, et al. N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis-C: a pilot study. J Interferon Res. 13:1993;279-282.
16. Barbaro G, Di Lorenzo G, Soldini M, Parrotto S, Bellomo G, Belloni G, et al. Hepatic glutathione deficiency in chronic hepatitis C: quantitative evaluation in patients who are HIV positive and HIV negative and correlations with plasmatic and lymphocytic concentrations and with the activity of the liver disease. Am J Gastroenterol. 91:1996;2569-2573.
17. Lamoureux GV, Whitesides GM. Synthesis of dithiols as reducing agents for disulfides in neutral aqueous solution and comparison of reduction potentials. J Org Chem. 58:1993;633-641.
18. Stofer-Vogel B, Cerny T, Kupfer A, Junker E, Lauterburg BH. Depletion of circulating cyst(e)ine by oral and intravenous mesna. Br J Cancer. 68:1993;590-593.
19. Burgunder JM, Varriale A, Lauterburg BH. Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration. Eur J Clin Pharmacol. 36:1989;127-131.
20. Chazouillères CO, Vaubourdolle M, Sabbah I, Serfaty L, Giboudeau J, Poupon R. Plasma concentration of reduced glutathione (GSH) and response to interferon (IFN) in patients with chronic hepatitis C [abstract]. Gastroenterology. 110:1996;1167.
21. Lim HL, Myers BM, Hamilton BA, Davis GL, Lau JYN. Plasma glutathione concentration in patients with chronic hepatitis C virus infection. J Viral Hepat. 2:1995;211-214.
22. Lauterburg BH, Velez ME. Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity. Gut. 29:1988;1153-1157.
23. Poulsen HE, Ranek L, Andreasen PB. The hepatic glutathione content in liver diseases. Scand J Clin Lab Invest. 41:1981;573-576.
24. Witschi A, Junker E, Schranz C, Speck RF, Lauterburg BH. Supplementation of N-acetylcysteine fails to increase glutathione in lymphocytes and plasma of patients with AIDS. AIDS Res Hum Retroviruses. 11:1995;141-143.
25. Cimino L, Intrieri M, D'Ascoli B, Belisario MA, Sacchetti L, Budillon G. The effect of N-acetyl-cysteine on lymphomonocyte glutathione and interferon responsiveness in C-virus chronic hepatitis [abstract]. Gastroenterology. 110:1996;1172.